The Stroke Improvement National Audit Programme (SINAP), commissioned by the Healthcare Quality Improvement Partnership (HQIP) and run by the Royal College of Physicians’ Stroke Programme, shows that 8% of patients received clot-busting treatment (thrombolysis) following a stroke, up from only 1%